Net Cash Provided by (Used in) Financing Activities in USD of Silo Pharma, Inc. from Q3 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Silo Pharma, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from Q3 2010 to 2024.
  • Silo Pharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$115K.
  • Silo Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $3.24M.
  • Silo Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$471K, a 110% decline from 2022.
  • Silo Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $4.94M, a 30.2% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Silo Pharma, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$115K Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-09
Q1 2021 $3.8M +$3.78M +25210% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2020 $15K +$24.8K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q1 2019 -$9.81K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q1 2013 $20K +$5K +33.3% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-15
Q1 2012 $15K +$14.4K +2509% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q1 2011 $575 Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 $8.5K Jul 13, 2010 Sep 30, 2010 10-Q 2011-11-10

Silo Pharma, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $3.24M +$3.71M Jan 1, 2024 Dec 31, 2024 10-K 2025-03-28
2023 -$471K -$5.41M -110% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-28
2022 $4.94M +$1.15M +30.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 $3.79M +$1.66M +77.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 $2.13M +$1.75M +458% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $383K +$363K +1867% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-05-17
2018 $19.5K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2013 $2.19M +$2.17M +10860% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-31
2012 $20K +$19.4K +3378% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-31
2011 $575 Jan 1, 2011 Dec 31, 2011 10-K 2014-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.